The Europe Ureteroscopy Market would witness market growth of 4.9% CAGR during the forecast period (2022-2028).
A tissue sample is taken during a biopsy and sent to a lab for additional analysis. Doctors frequently perform this operation when they suspect a tumor in any organ. If any malignant development is discovered in the kidneys or ureters, for instance, instruments are inserted through a ureteroscope to do a biopsy. A disorder called ureterovaginal fistula occurs when the ureters and vagina can communicate. Urinary incontinence is caused when urine from the ureters leaks into the vagina (urine leakage).
The most effective and preferable procedure for ureterovaginal fistula diagnosis is ureteroscopy. Although ureteroscopy is primarily a diagnostic procedure, kidney stones can also be removed using it as a less invasive treatment. A ureteroscopy used for therapeutic purposes involves the removal of stones using forceps or a small wire basket that is linked to the endoscope. No cuts or incisions are made at any point during the procedure.
Germany is the biggest market in Europe and among the biggest markets worldwide for medical technology. Foreign investors have some prospects to invest in this country due to the government's funding effort for health informatics and other initiatives, including the digitalization of healthcare. For instance, North Rhine-public Wesrphalia's hospitals have started to modernize their current buildings and re-organize their system. The regional government has a positive outlook on the adoption of novel medical technology and apparatus. The growing healthcare infrastructure and the expanding medical technology sector would support the regional market growth for ureteroscopy over the course of the projection period.
The Germany market dominated the Europe Ureteroscopy Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $76 Million by 2028. The UK market is anticipated to grow at a CAGR of 4.1% during (2022 - 2028). Additionally, The France market would exhibit a CAGR of 5.7% during (2022 - 2028).
Based on End User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on Product, the market is segmented into Flexible, and Semi- Rigid. Based on Application, the market is segmented Urolithiasis, Urinary Stricture, Kidney Cancer, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Ureteroscopy Market will Hit $1.1 Billion by 2028, at a CAGR of 5.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Olympus Corporation, Hoya Corporation, Steris PLC, Stryker Corporation, Advin Health Care, Karl Storz SE & Co. KG, Richard Wolf GmbH, Cliniva Healthcare, and OTU Medical Inc.
By End User
By Product
By Application
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
